As noted in an earlier post here, the U.S. Supreme Court is expected to issue an opinion in the Dobbs v. Jackson Women’s Health case sometime before its recess in July. A draft majority opinion, authored by Justice Samuel Alito and overturning Roe v. Wade, was leaked to news media in May.
While we won’t know the actual content or ruling of the decision until it is officially released, the leaked majority opinion gives a good indication that the precedent of Roe is either going to be overturned or severely limited. In anticipation of that occurring, Reed Smith has gathered a Reproductive Health Working Group consisting of attorneys and experts across the firm to provide analysis on the potential effects of the Dobbs decision.
As part of that effort, Scot Hasselman, Lesley Reynolds, Sarah Cummings Stewart, and John Kendzior have put together the first of a number of client updates that should provide some clarity for what the expected overturn of Roe will mean for various health care entities. This first installment covers the unanswered questions for pharmacies should Roe be overturned.
The client update is available here.
Reed Smith will continue to monitor Supreme Court decisions as well as any state or federal responses to those decisions. If you have any questions about this topic or how the Court’s eventual opinion will affect your organization legally, please reach out to the health care lawyers at Reed Smith.